How Important Is Acupressure Application in Balancing Heart Rate and Blood Pressure in the Treatment of Atrial Fibrillation? Single-Blind Randomized Experimental Study
1 other identifier
interventional
69
1 country
1
Brief Summary
Atrial fibrillation is a common cardiac arrhythmia affecting 1-2% of the population. This rate is expected to increase in the next 30 years. The aim of this study is to determine the effect of acupressure applied to patients with chronic atrial fibrillation on blood pressure and heart rate. This study was designed as a randomized, placebo-controlled experimental study. As a result of the power analysis, 3 groups were formed, each consisting of 23 subjects. No procedure was applied to the control group before and after the measurements. In patients in the placebo group, an inverted and loose acupressure wristband was attached to the Shenman point to avoid applying pressure to any part of the wrist. Acupressure wristbands were applied towards the Shenmen point to provide adequate pressure to the patients in the intervention group and acupressure was applied twice a day. Acupressure was applied 4 times in two days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable atrial-fibrillation
Started Feb 2018
Shorter than P25 for not_applicable atrial-fibrillation
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2018
CompletedFirst Submitted
Initial submission to the registry
April 6, 2022
CompletedFirst Posted
Study publicly available on registry
April 28, 2022
CompletedMarch 27, 2023
March 1, 2023
Same day
April 6, 2022
March 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Investigation of the effect of acupressure applied to patients with Atrial Fibrillation on systole blood pressure, diastolic blood pressure and heart rate
The first criterion was planned to examine and report the effect of acupressure on systole blood pressure.
6 months
Secondary Outcomes (1)
Investigation of the effect of acupressure applied to patients with Atrial Fibrillation on systole blood pressure, diastolic blood pressure and heart rate
6 months
Other Outcomes (1)
Investigation of the effect of acupressure applied to patients with Atrial Fibrillation on systole blood pressure, diastolic blood pressure and heart rate
6 months
Study Arms (3)
Acupressure group
EXPERIMENTALThe patients in the intervention group were informed about what acupressure was and why it was applied. An acupressure wristband was correctly worn on both wrists to provide patients with adequate pressure on the HT7 point for 5 minutes
Placebo Group
PLACEBO COMPARATORPatients in the placebo group were informed about what acupressure was and why it was applied. In order not to apply pressure to the Shenmen (HT7) pressure point in the patients in this group, the acupressure wristband was placed on both wrists in an inverted and loose manner and the wristband was worn for 5 minutes, the procedure was completed.
Control group
NO INTERVENTIONNo procedure was applied to the patients in the control group. The patients received routine treatment and care.
Interventions
The acupressure wristband was correctly attached to the Experimental Group and acupressure was applied. The placebo group was fitted with an inverted and loose acupressure wristband. No intervention was applied to the control group.
Eligibility Criteria
You may qualify if:
- \>18 years of age
- Fully conscious
- Oriented and cooperative
- Heart rate of 70-120 beats/min
- No history of recent open heart surgery
You may not qualify if:
- Patients with renal failure (which causes deterioration of heart rhythm and structure)
- Liver failure (which affects hemodynamic balance)
- Hyperthyroidism (increased pulse rate) were excluded from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
KahramanmarasSIU
Kahramanmaraş, 46100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 6, 2022
First Posted
April 28, 2022
Study Start
February 20, 2018
Primary Completion
February 20, 2018
Study Completion
July 20, 2018
Last Updated
March 27, 2023
Record last verified: 2023-03